Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SHREE RAJASTHAN SYNTEX LTD.

NSE : NABSE : 503837ISIN CODE : INE796C01011Industry : Textile - Manmade FibresHouse : Private

BSE16.85-0.6 (-3.44 %)

PREV CLOSE ( ) 17.45

OPEN PRICE ( ) 18.32

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7027

TODAY'S LOW / HIGH ( )16.60 18.32

52 WK LOW / HIGH ( ) 9.5627.77

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Operational & Financial Ratios

Earnings Per Share (Rs)

-5.13

40.04

-31.60

-26.59

-17.62

CEPS(Rs)

-4.71

40.72

-16.74

-23.39

-14.42

DPS(Rs)

0.00

Book NAV/Share(Rs)

-0.31

4.72

-83.17

-51.48

-24.94

Tax Rate(%)

0.00

-0.17

0.00

Margin Ratios

Core EBITDA Margin(%)

-109.08

-34.00

-4.98

-8.89

-8.65

EBIT Margin(%)

-98.37

450.18

-42.48

-17.17

-16.28

Pre Tax Margin(%)

-108.04

443.54

-83.72

-71.75

-65.91

PAT Margin (%)

-108.04

443.54

-83.86

-71.75

-65.91

Cash Profit Margin (%)

-99.21

451.09

-44.41

-63.12

-53.94

Performance Ratios

ROA(%)

-38.98

158.36

-40.99

-29.99

-17.60

ROE(%)

-232.71

0.00

ROCE(%)

-67.50

3213.37

0.00

-24.14

-8.33

Asset Turnover(x)

0.36

0.49

0.42

0.27

Sales/Fixed Asset(x)

0.10

0.14

0.24

0.17

Working Capital/Sales(x)

-1.04

-1.59

-0.26

-0.29

-0.25

Efficiency Ratios

Fixed Capital/Sales(x)

10.18

7.00

4.16

4.22

5.85

Receivable days

10.92

10.70

8.17

7.56

10.43

Inventory Days

23.65

13.77

10.05

17.38

39.91

Payable days

451.70

430.01

226.73

218.03

353.63

Valuation Parameters

PER(x)

0.00

0.17

0.00

PCE(x)

-3.06

0.17

-0.21

-0.18

0.00

Price/Book(x)

-46.80

1.48

-0.04

-0.08

0.00

Yield(%)

0.00

EV/Net Sales(x)

3.92

1.31

1.90

1.86

2.76

EV/Core EBITDA(x)

-4.72

9.57

-68.41

-21.75

-64.12

EV/EBIT(x)

-3.99

0.29

-4.47

-10.83

-16.97

EV/CE(x)

4.68

1.20

-4.77

0.81

0.80

M Cap / Sales

3.04

0.78

0.09

0.12

0.00

Growth Ratio

Net Sales Growth(%)

-47.37

-51.03

1.70

38.61

-47.16

Core EBITDA Growth(%)

-419.38

341.36

66.97

-175.11

34.84

EBIT Growth(%)

-111.50

619.01

-151.53

-46.22

12.75

PAT Growth(%)

-112.82

359.02

-18.86

-50.88

-11.24

EPS Growth(%)

-112.82

226.70

-18.86

-50.88

-11.24

Financial Stability Ratios

Total Debt/Equity(x)

-13.90

1.09

-0.82

-1.26

-2.58

Current Ratio(x)

0.18

0.17

0.03

0.04

0.06

Quick Ratio(x)

0.12

0.13

0.02

0.03

0.04

Interest Cover(x)

-10.18

67.75

-1.03

-0.31

-0.33

Total Debt/Mcap(x)

0.30

0.74

19.48

14.99